This content is machine translated Apremilast PDE4 inhibition in the treatment of inflammatory diseases. The PDE-4 inhibitor apremilast was discussed as a potential option in the treatment of psoriatic arthritis at this year’s ACR Congress in San Diego. Promising results show good efficacy both…
